Physical Therapists in New York, NY Accepting Medicare

4080 Physical Therapists found. Showing 201 - 220

Ms. Luanne Sforza, PT Physical Therapist - Orthopedic Medicare: Accepting Medicare Assignments Practice Location: 32 Union Sq E, 7th Floor, New York, NY 10003 Phone: 914-649-8763    Fax: 212-529-6409

Ma. Shelly Go Lao, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 460 Grand St, Ground Floor, New York, NY 10002 Phone: 212-539-0257

Dr. George Emmanuel Xenakis, D.P.T Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 423 E 23rd St, New York, NY 10010 Phone: 212-686-7500

Ms. Lillian Taliaferro, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 10571 Flatlands 9 Street, New York, NY 11236 Phone: 347-886-6694

Fortius Physical Therapy, Pllc Physical Therapist Medicare: Medicare Enrolled Practice Location: 850 7th Ave, Suite 905, New York, NY 10019 Phone: 212-757-7110    Fax: 212-757-7333

Imperial Physical Therapy Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 369 Lexington Avenue 16th Floor, New York, NY 10017 Phone: 646-861-1203    Fax: 212-943-1999

Laksman D. Shapiro, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 162 W 72nd St Fl 4, New York, NY 10023 Phone: 212-861-2630    Fax: 212-861-2685

Bhavana Jain Physical Therapist Medicare: Medicare Enrolled Practice Location: 1110 2nd Ave Rm 302, New York, NY 10022 Phone: 212-842-0080

Senthil Kumar Srinivasan Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 61 Broadway Rm 2824, New York, NY 10006 Phone: 212-981-1981

Anuj Shah, PT, MA Physical Therapist Medicare: Medicare Enrolled Practice Location: 1110 2nd Ave, Suite 302, New York, NY 10022 Phone: 212-842-0080

Mr. Shourin Roy, RPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 185 Claremont Ave, Apt 4b, New York, NY 10027 Phone: 646-683-1140

Pt Affiliated With Hss - Nyac Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 180 Central Park S, Pt Affiliated With Hss - Nyac, New York, NY 10019 Phone: 212-767-7114

Timeless Physical Therapy Pc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 81 Elizabeth St Ste 303, New York, NY 10013 Phone: 212-219-8987    Fax: 212-219-8982

Claire R Weisenfels, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 16 E 52nd St Fl 6, New York, NY 10022 Phone: 347-943-8046

Rendalyn Tan Physical Therapist Medicare: Medicare Enrolled Practice Location: 465 Grand St, New York, NY 10002 Phone: 917-780-7118

Spear Physical And Occupational Therapy, Llc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 16 Park Place, New York, NY 10007 Phone: 212-759-2282

Professional Occupational & Physical Therapy, Pllc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 240 E 54th St, New York, NY 10022 Phone: 212-371-7001    Fax: 212-371-7011

Dr. Terence Michael Crossan Jr., DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 143 E 34th St, New York, NY 10016 Phone: 646-841-1400    Fax: 212-379-2118

Alexander Zhao, PT, DPT, MS Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 36 W 44th St Ste 403, New York, NY 10036 Phone: 212-759-2280    Fax: 212-938-0015

Corey Bindler, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 37 W 20th St Ste 806, New York, NY 10011 Phone: 212-226-2066

News Archive

New era drug gives hope to Gleevec resistant leukaemia sufferers

Gleevec, a drug regarded by many as having "wonder drug" capabilities in the treatment of chronic myelogenous leukaemia (CML) and other cancers, has been revealed as having shortcomings in that some patients have undergone a relapse after building a resistance to the drug. For others with the advanced stage of the disease, the drug has failed to produce durable remissions.

Igenica raises $33M in Series C round of funding

Igenica, Inc., a leading biopharmaceutical company focused on the discovery and development of first-in-class antibodies, today announced that it has raised $33 million in a Series C round of funding.

Emerging pharmacologic approach may inhibit NASH

Treating a liver disease called NASH (non-alcoholic steatohepatitis), which affects 10 to 15 percent of obese individuals with type-2 diabetes worldwide, is difficult. But now scientists believe they have found a pharmacologic approach that may inhibit NASH, and thus stop deadly conditions that result from NASH such as cirrhosis and liver cancer.

Sanofi-aventis receives FDA approval for new Taxotere Injection Concentrate formulation

Sanofi-aventis U.S. announced today that the U.S. Food and Drug Administration (FDA) has approved a new one-vial formulation of its chemotherapeutic agent Taxotere® (docetaxel) Injection Concentrate. The 1-vial Taxotere is anticipated to become available to cancer treatment clinics and hospitals nationwide in the fall in both 80 mg and 20 mg dosages.

Read more Medical News

› Verified 9 days ago

• «
• 6
• 7
• 8
• 9
• 10
• 11(current)
• 12
• 13
• 14
• 15
• 16
• »